2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Brain Neoplasms
2
Supranuclear Palsy, Progressive
1
Spinal Cord Injuries
1
Prostatic Neoplasms
1
Parkinson Disease
1
Myasthenia Gravis
1
Multiple System Atrophy
1
Lewy Body Disease
1
Hematologic Neoplasms
1
Head and Neck Carcinoma
1
Fatigue
1
Essential Tremor
1
Carcinoma, Renal Cell
1
Alzheimer Disease
1
Interventions
Dexamethasone
4
Electroencephalography
3
XENP 1595
2
Methods
2
selinexor
1
pomalidomide
1
ixazomib
1
fasudil
1
birtamimab
1
UE2343
1
Transurethral Resection of Bladder
1
Telemedicine
1
Tablets
1
Surgical Procedures, Operative
1
Standard of Care
1
Rosiglitazone
1
Propofol
1
Positron-Emission Tomography
1
Neurofeedback
1
Methotrexate
1
Melphalan
1
Mass Screening
1
Magnetic Resonance Imaging
1
Lysine Acetyltransferase 5
1
Hypnosis
1
Hormones
1
Exercise
1
Ethanol
1
Drug Delivery Systems
1
Donepezil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Alzheimer Disease
×
Neurofeedback
×
Clear all
NCT02761707
2019-07-18
Biomarkers in Neural Disorders
University of Pennsylvania
Completed
54 enrolled